Metraipolis › archive › dc_c7cd5b66acbb

TRAIL-PEG-Apt-PLGA nanosystem as an aptamer-targeted drug delivery system potential for triple-negative breast cancer therapy using in vivo mouse model — Europe PMC PMID:41656578

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41656578
DOI
10.1002/1878-0261.70202
License (as archived)
solo-consultazione
Archived
2026-11-06T01:01:01.384Z
SHA-256 of the archived text
98179f3d381954eb63fe3b8ac92b1f64b44027d17f9f6f2197d81ce63b0b22da
Stable URL of this page
https://metraipolis.com/documento/dc_c7cd5b66acbb

How to cite

TRAIL-PEG-Apt-PLGA nanosystem as an aptamer-targeted drug delivery system potential for triple-negative breast cancer therapy using in vivo mouse model — Europe PMC PMID:41656578 — Europe PMC (en), https://europepmc.org/article/MED/41656578 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c7cd5b66acbb (Metraipolis archive dc_c7cd5b66acbb, sha256 98179f3d381954eb63fe3b8ac92b1f64b44027d17f9f6f2197d81ce63b0b22da)
BibTeX
@misc{dcc7cd5b66acbb,
  title = {TRAIL-PEG-Apt-PLGA nanosystem as an aptamer-targeted drug delivery system potential for triple-negative breast cancer therapy using in vivo mouse model — Europe PMC PMID:41656578},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41656578},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c7cd5b66acbb; sha256 98179f3d381954eb63fe3b8ac92b1f64b44027d17f9f6f2197d81ce63b0b22da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41656578. Agents can read the archived copy with the MCP tool read_document.